For instance, in HCC patients, the expression of PD-1 is upregulated in CD8+ T cells and an increased number of circulating and tumor-infiltrating PD-1+/CD8+ T cells are seen which are associated with progression of HCC (Shi et al., 2011; Jubel et al., 2020). The gene discussed is CD8A; the disease is hepatocellular carcinoma.